Checking the COA half-life data alongside your storage conditions ensures the compound in your hands matches the quality documented at time of manufacture
BPC-157 (body protection compound-157) is a peptide derived from human gastric juice that is 15 amino acids in length
We create a comprehensive and sustainable solution for your journey to better health
What to monitor Track the following metrics to assess whether the levocarnitine addition is providing value: Body composition changes (use DEXA, InBody, or similar if accessible) Energy levels and exercise performance GI symptoms (compare to baseline on tirzepatide alone if possible) Liver function markers (ALT, AST) if baseline values were elevated General well-being and recovery quality If after 8 to 12 weeks the levocarnitine addition has not produced noticeable improvements in energy, exercise performance, or body composition compared to tirzepatide alone, consider adjusting your protocol or switching to a different compound blend
The report, "New Weight Loss Drugs: GLP-1 Agonist Use and Side Effects in the United States," is available at www.rand.org
Theres no published human evidence showing they work